vimarsana.com
Home
Live Updates
The Native Antigen Company expands infectious disease portfo
The Native Antigen Company expands infectious disease portfo
The Native Antigen Company expands infectious disease portfolio to include Sudan Ebolavirus Boniface 1976 Glycoprotein
The Native Antigen Company (part of LGC Clinical Diagnostics), one of the world's leading suppliers of reagents that enables research into vaccines and diagnostics for emerging and endemic infectious...
Related Keywords
Sudan ,
Uganda ,
Pardeep Sharda ,
Ebolavirus Boniface ,
Antigen Company ,
From The Native Antigen Companydec ,
Native Antigen Company ,
Sudan Ebolavirus Boniface ,
Sudan Ebolavirus ,
C Terminal His Tag ,
Senior Product Manager ,
Antigen ,
Lycoprotein ,
Antibodies ,
Clinical Diagnostics ,
Iagnostics ,
Immunoassay ,
Infectious Diseases ,
Protein ,
Eagents ,
Research ,
Vaccine ,
Virus ,